Mesenchymal Stem Cells Loaded with p5, Derived from CDK5 Activator p35, Inhibit Calcium-Induced CDK5 Activation in Endothelial Cells
The potential use of stem cells as therapeutics in disease has gained momentum over the last few years and recently phase-I clinical trials have shown favourable results in treatment of a small cohort of acute stroke patients. Similarly, they have been used in preclinical models drug-loaded for the...
| Glavni autori: | , , , , , , , , , |
|---|---|
| Format: | Članak |
| Jezik: | English |
| Izdano: |
Hindawi Limited
2016-01-01
|
| Serija: | Stem Cells International |
| Online pristup: | http://dx.doi.org/10.1155/2016/2165462 |